Countries China

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

 WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

 November 24, 2022 | News

The 13th China (Taizhou) International Medical Expo successfully held

During the event, 20 projects with a total investment of about 7.1 billion yuan were signed intensively, covering fields such as vaccines, antibo...

 November 24, 2022 | News

Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the Investigational New Drug (IND) application by China National Medical Prod...

 November 17, 2022 | News

Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China

MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The vaccine incorporates five distinct RSV antigens...

 November 15, 2022 | News

Mednovation Entered Into Strategic Cooperation With LSI

Under the agreed arrangement, which is effective as of this release, Mednovation shall be the preferred partner of LSI for its partnering events, seminars,...

 November 15, 2022 | News

Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...

 November 14, 2022 | News

XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics

Xi'an Jiaotong-Liverpool University (XJTLU) researchers conduct world-class biopharmaceutical research at the University's Suzhou Industrial Park (SIP) c...

 November 09, 2022 | News

Himalaya Therapeutics Announces Highlights of Recent Clinical Progress

Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled HTBA3011 Undif...

 November 09, 2022 | News

Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China

Merck to offer its first-to-market Blazar ® Rodent Panel for virus testing Reduces biosafety turnaround time by up to 80% Reduces animal ...

 November 08, 2022 | News

Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

 November 07, 2022 | News

NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is announc...

 November 03, 2022 | News

Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery

The operation was performed by the team of Professor and Dr. Xiaofeng Zhang, vice president of Hangzhou First People's Hospital and director of the Ce...

 November 03, 2022 | News

WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China

The facility's design incorporates environmental protection, energy conservation, emission reduction, and resource utilization – a reflection of WuXi...

 October 26, 2022 | News

Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging

The IND application was submitted in partnership with Grand Pharmaceutical Group Limited (Grand Pharma), Telix's partner in the Greater China reg...

 October 17, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in